Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector
Marine Drugs · 13.05.2025 · 23 (5) · 207
DOI: 10.3390/md23050207 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 13.05.2025. Verfasst von Laura M Teixeira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal. Hauptthemen laut MEDLINE: Aquatic Organisms, Nanoparticles, Biological Products. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia (FCT), Instituto Politécnico de Lisboa (IPL).
Abstract (Originalsprache)
The ocean is an extraordinary natural source of a wide range of bioactive compounds. These compounds, including proteins, phenolics, polysaccharides, pigments, vitamins, and fatty acids, possess unique biological properties that are increasingly being explored in the field of nanotechnology across diverse sectors. Among marine-derived nanoparticles, promising applications have emerged in the biomedical and pharmaceutical fields, particularly metallic nanoparticles and polysaccharide-based drug delivery systems. This review provides a unique perspective on the integration of two research areas: the exploration of marine bioresources as bioactive compounds sources with nanotechnological methodologies to develop sustainable, safe, stable and functional marine-derived NPs. It highlights recent advancements in the green synthesis of MNPs and the formulation of drug delivery systems using marine polysaccharides. This review also describes the recent trends over the past ten years and discusses the major challenges and limitations associated with these approaches, including variability in biological sources, batch-to-batch inconsistency, mechanistic uncertainties, and difficulties in reproducibility and scalability. Furthermore, it emphasizes the need for standardized protocols and the integration of life cycle assessments (LCA) to evaluate environmental and economic viability for effective translating marine-derives nanoparticles from research to clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
- Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
- Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
- Instituto de Biofísica e Engenharia Biomédica (IBEB), Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
- Departamento de Engenharia Química, Instituto Superior de Engenharia de Lisboa, 1959-007 Lisboa, Portugal.
ORCID-Profile: Laura M Teixeira, Catarina P Reis, Rita Pacheco
Förderung
- Fundação para a Ciência e Tecnologia (FCT)
- Instituto Politécnico de Lisboa (IPL)
Zitieren
APA
Teixeira, L. M., Reis, C. P., & Pacheco, R. (2025). Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector. Marine Drugs, 23(5), 207. https://doi.org/10.3390/md23050207
Vancouver
Teixeira LM, Reis CP, Pacheco R. Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector. Marine Drugs. 2025;23(5):207. doi:10.3390/md23050207
BibTeX
@article{Teixeira2025,
author = {Teixeira, Laura M and Reis, Catarina P and Pacheco, Rita},
title = {Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {5},
pages = {207},
doi = {10.3390/md23050207}
}
EUVIMED